Lithium Citrate
FDA-approved product (syrup, oral), marketed as Lithium Citrate, Lithonate, Potassium Citrate and 1 more.
- Registered studies
- 50+
- Lab records
- 0
- Pathogens at ≥40%
- 0 of 4
Chemical structure
Existing / approved use
Documented · FDA, WHO, ChEMBLApproved for
- Anemia (phenotype)
- Bipolar I disorder
- Major depressive disorder
- Renal tubular acidosis
Indications ChEMBL records as approved, from FDA and DailyMed labels. Label ↗
- WHO therapeutic group
- Potassium; Salt solutions
- Anti-infective classification
- Not classified as an anti-infective.
Repurposing investigation
No supported pathogen reaches ≥40% AI-predicted activity for Lithium Citrate, so it is not among the repurposing candidates. Its predictions are shown below.
AI-predicted activity
AI prediction · nothing measured- MRSA11.0% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- E. coli14.8% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- K. pneumoniae10.6% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- M. tuberculosis27.5% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
A model’s estimate of laboratory activity against each pathogen species. It is not clinical effectiveness.
Evidence
Clinical and experimental
Documented evidenceClinical
50+registered studies name this medicine, for any condition. The registry search keeps the first 50, so there may be more. See them below.
Experimental
No evidence found
No laboratory measurement against the four pathogens in the ChEMBL records loaded here.
Docking
Computational · nothing measuredDihydrofolate reductase ↗ (E. coli)
Not yet docked: queued in the docking rundetails
KPC-2 carbapenemase ↗ (K. pneumoniae)
Not yet docked: queued in the docking rundetails
Enoyl-ACP reductase (InhA) ↗ (M. tuberculosis)
Not yet docked: queued in the docking rundetails
Dihydrofolate reductase ↗ (MRSA)
Not yet docked: queued in the docking rundetails
AutoDock Vina, one experimentally solved protein per pathogen. This project’s screening target is -7.0 kcal/mol, its own mark rather than a universal cutoff. A docking score is a structural hypothesis, not proof of binding, and requires experimental validation.
Other medicines to investigate
AI prediction · nothing measuredOther repurposing candidates: approved medicines besides Lithium Citrate with AI-predicted activity ≥40% against the chosen pathogen, leaving out existing antimicrobials. They are computational candidates for further investigation, not alternatives and not recommendations.
Sorted by AI-predicted activity, high to low. The order is not a ranking of which medicine is better.
- FurazolidoneExisting use: Other antiinfectives and antiseptics91.4% AI-predicted activityagainst M. tuberculosisLab records exist49 registered studies
- TriflupromazineExisting use: Psychosis90.6% AI-predicted activityagainst M. tuberculosisNo documented evidence found
- ValdecoxibExisting use: Dysmenorrhea, Osteoarthritis, Rheumatic disease and 1 more88.6% AI-predicted activityagainst M. tuberculosisLab records exist31 registered studies
- CelecoxibExisting use: Ankylosing spondylitis, Cancer, Colorectal neoplasm and 15 more87.6% AI-predicted activityagainst M. tuberculosisLab records exist50+ registered studies
- Dorzolamide HydrochlorideExisting use: Glaucoma, Ocular hypertension, Open-angle glaucoma86.8% AI-predicted activityagainst M. tuberculosisLab records exist50+ registered studies
- MethazolamideExisting use: Glaucoma, Open-angle glaucoma85.6% AI-predicted activityagainst M. tuberculosisLab records exist11 registered studies
- AcetazolamideExisting use: Altitude sickness, Angle-closure glaucoma, Congestive heart failure and 5 more85.2% AI-predicted activityagainst M. tuberculosisLab records exist50+ registered studies
- Trifluoperazine HydrochlorideExisting use: Anxiety disorder, Mental or behavioural disorder, Psychosis and 1 more84.6% AI-predicted activityagainst M. tuberculosis1 registered study
- TriclosanExisting use: Phenol and derivatives, Medicated dressings with antiinfectives84.2% AI-predicted activityagainst M. tuberculosisLab records exist50+ registered studies
- NitrofurazoneExisting use: Eye infection, Leishmaniasis, Trypanosomiasis84.0% AI-predicted activityagainst M. tuberculosis8 registered studies
- BrinzolamideExisting use: Glaucoma, Ocular hypertension, Open-angle glaucoma83.8% AI-predicted activityagainst M. tuberculosisLab records exist50+ registered studies
- ZonisamideExisting use: Epilepsy, Focal-onset seizure, Partial epilepsy and 1 more82.8% AI-predicted activityagainst M. tuberculosisLab records exist50+ registered studies
Registered studies
A registration describes a study; it does not establish a positive result.
Clinical Behavior and Patient Satisfaction of Zirconia-reinforced Glass-ceramic Crowns and Ultra-translucent-multilayered Monolithic Zirconia Crowns With a Conservative Marginal Design
NCT07521501 · start 2026-06-01
Registered record
- Registry ID
- NCT07521501
- Conditions
- Clinical Behavior of ZLS and UTML
- Interventions
- UTML (KATANA) crowns with conservative marginal design; ZLS (AMBRIA) crowns with conservative marginal design
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Not yet recruiting
- Start
- 2026-06-01
- Completion
- 2027-07-01
- Enrolment
- 20
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionClinical Behavior of ZLS and UTMLInterventionUTML (KATANA) crowns with conservative marginal design; ZLS (AMBRIA) crowns with conservative marginal designPhaseNot applicableRegistry statusNot yet recruitingBioHPP and Lithium Disilicate Onlay Restorations: Clinical Evaluation
NCT07142031 · start 2025-09-15
Registered record
- Registry ID
- NCT07142031
- Conditions
- Dental Caries; Polymers
- Interventions
- BioHPP; Lithium Disilicate
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Active not recruiting
- Start
- 2025-09-15
- Completion
- 2026-10-15
- Enrolment
- 40
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionDental Caries; PolymersInterventionBioHPP; Lithium DisilicatePhaseNot applicableRegistry statusActive not recruitingA Study Evaluating 24 Months of Lithium Carbonate Treatment in Patients With TBR1-related Neurocognitive Disorder
NCT06776848 · start 2025-09-12
Registered record
- Registry ID
- NCT06776848
- Conditions
- Proven Pathogenic or Probably Pathogenic TBR1 Variant
- Interventions
- Observation phase; Lithium treatment; biological monitoring
- Study type
- INTERVENTIONAL
- Phase
- Phase 1 / Phase 2
- Registry status
- Recruiting
- Start
- 2025-09-12
- Completion
- 2027-09-12
- Enrolment
- 12
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionProven Pathogenic or Probably Pathogenic TBR1 VariantInterventionObservation phase; Lithium treatment; biological monitoringPhasePhase 1 / Phase 2Registry statusRecruitingDevelopment and Application of Precision Treatment Strategies for Common Mental Disorders
NCT06729541 · start 2024-11-11
Registered record
- Registry ID
- NCT06729541
- Conditions
- Depression - Major Depressive Disorder; Schizophrenia Disorders; Bipolar Disorder (BD)
- Interventions
- Multigenetic Pharmacogenomics-Guided Treatment (MPGT)
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Recruiting
- Start
- 2024-11-11
- Completion
- 2026-12
- Enrolment
- 600
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionDepression - Major Depressive Disorder; Schizophrenia Disorders; Bipolar Disorder (BD)InterventionMultigenetic Pharmacogenomics-Guided Treatment (MPGT)PhaseNot applicableRegistry statusRecruitingBioequivalence Study of Lithium Carbonate 300 mg Tablets. Actilitio® in Healthy Subjects
NCT06861842 · start 2024-06-01
Registered record
- Registry ID
- NCT06861842
- Conditions
- Healthy; Healthy Donors
- Interventions
- Theralite®; Actilitio®
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Active not recruiting
- Start
- 2024-06-01
- Completion
- 2025-04-30
- Enrolment
- 24
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionHealthy; Healthy DonorsInterventionTheralite®; Actilitio®PhasePhase 4Registry statusActive not recruitingEndodontic Posts Using the CAD/CAM Digital Method.
NCT07297108 · start 2023-11-30
Registered record
- Registry ID
- NCT07297108
- Conditions
- Endodontic Treatment; Tooth Restoration
- Interventions
- Lithium Disilicate CAD/CAM Post; Active Comparator: Polymer-Based CAD/CAM Posts
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Active not recruiting
- Start
- 2023-11-30
- Completion
- 2029-11-30
- Enrolment
- 80
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionEndodontic Treatment; Tooth RestorationInterventionLithium Disilicate CAD/CAM Post; Active Comparator: Polymer-Based CAD/CAM PostsPhaseNot applicableRegistry statusActive not recruitingClinical Evaluation of Implants Restored With Advanced Lithium Disilicate Screw-retained Crowns
NCT05752539 · start 2023-10-10
Registered record
- Registry ID
- NCT05752539
- Conditions
- Dental Prosthesis Failure; Dental Prosthesis Complication
- Interventions
- CEREC System by Dentsply Sirona
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Active not recruiting
- Start
- 2023-10-10
- Completion
- 2028-02-20
- Enrolment
- 25
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionDental Prosthesis Failure; Dental Prosthesis ComplicationInterventionCEREC System by Dentsply SironaPhaseNot recordedRegistry statusActive not recruitingEndogenous Lithium Clearance in Acute Kidney Injury
NCT05982340 · start 2023-08-01
Registered record
- Registry ID
- NCT05982340
- Conditions
- Acute Kidney Injury Due to Sepsis; Proximal Tubule Function; Lithium Clearance
- Interventions
- Lithium clearance
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Completed
- Start
- 2023-08-01
- Completion
- 2025-05-20
- Enrolment
- 20
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionAcute Kidney Injury Due to Sepsis; Proximal Tubule Function; Lithium ClearanceInterventionLithium clearancePhaseNot recordedRegistry statusCompletedDigital Decision Support in the Management of Patients With Chest Pain
NCT05767619 · start 2023-05-15
Registered record
- Registry ID
- NCT05767619
- Conditions
- Chest Pain; Acute Coronary Syndrome; Chest--Diseases
- Interventions
- Troponin hs-cTnI; Plasma glucose
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Recruiting
- Start
- 2023-05-15
- Completion
- 2027-03
- Enrolment
- 2,000
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionChest Pain; Acute Coronary Syndrome; Chest--DiseasesInterventionTroponin hs-cTnI; Plasma glucosePhaseNot recordedRegistry statusRecruitingAMIloride for the Treatment of Nephrogenic Diabetes Insipidus for Patients With Bipolar Disorder Treated With Lithium
NCT05044611 · start 2023-01-11
Registered record
- Registry ID
- NCT05044611
- Conditions
- Bipolar Disorder
- Interventions
- Anhydrous Amiloride Hydrochloride; Placebo
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Active not recruiting
- Start
- 2023-01-11
- Completion
- 2026-01-11
- Enrolment
- 148
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionBipolar DisorderInterventionAnhydrous Amiloride Hydrochloride; PlaceboPhasePhase 4Registry statusActive not recruitingEndocrown Restoring First Permanent Molar in Children
NCT06432049 · start 2022-12-05
Registered record
- Registry ID
- NCT06432049
- Conditions
- Comparing Different Types of Restorations for Restoring Endodontically Treated Permanent First Molar in Children
- Interventions
- restoration for endodontically treated molar
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2022-12-05
- Completion
- 2024-05-13
- Enrolment
- 30
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionComparing Different Types of Restorations for Restoring Endodontically Treated Permanent First Molar in ChildrenInterventionrestoration for endodontically treated molarPhaseNot applicableRegistry statusCompletedThe Use of Wireless Sensors in Neonatal Intensive Care
NCT04956354 · start 2022-08-15
Registered record
- Registry ID
- NCT04956354
- Conditions
- Preterm Birth; Apnea of Newborn
- Interventions
- ANNE™ Monitoring System (2 sensors) - version B; ANNE™ Monitoring System (2 sensors) - version C; ANNE™ Monitoring System (2 sensors) - version C
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Active not recruiting
- Start
- 2022-08-15
- Completion
- 2026-07
- Enrolment
- 75
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionPreterm Birth; Apnea of NewbornInterventionANNE™ Monitoring System (2 sensors) - version B; ANNE™ Monitoring System (2 sensors) - version C; ANNE™ Monitoring System (2 sensors) - version CPhaseNot recordedRegistry statusActive not recruitingClinical Evaluation of Lithium Disilicate and Hybrid Nano-ceramic Anterior Endocrowns (Randomized Clinical Trial)
NCT04757428 · start 2022-08-11
Registered record
- Registry ID
- NCT04757428
- Conditions
- Personal Satisfaction
- Interventions
- Endocrown
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2022-08-11
- Completion
- 2023-08-11
- Enrolment
- 20
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionPersonal SatisfactionInterventionEndocrownPhaseNot applicableRegistry statusCompletedMultiple Ascending Dose Safety, Tolerability, PK Study of AL001 in Alzheimer's Disease Patients & Healthy Adult Subjects
NCT05363293 · start 2022-05-04
Registered record
- Registry ID
- NCT05363293
- Conditions
- Alzheimer's Disease; Healthy Non-elderly and Elderly Adults
- Interventions
- AL001; Placebo
- Study type
- INTERVENTIONAL
- Phase
- Phase 1 / Phase 2
- Registry status
- Completed
- Start
- 2022-05-04
- Completion
- 2023-05-15
- Enrolment
- 65
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionAlzheimer's Disease; Healthy Non-elderly and Elderly AdultsInterventionAL001; PlaceboPhasePhase 1 / Phase 2Registry statusCompletedHemodynamics During Induction of General Anesthesia After Prophylactic Ephedrine, Phenylephrine or Norepinephrine.
NCT03864094 · start 2022-03-15
Registered record
- Registry ID
- NCT03864094
- Conditions
- Hemodynamic Instability; Anesthesia, General; Anesthesia, Intravenous
- Interventions
- Ephedrine; Phenylephrine; Norepinephrine; Sodium chloride; Propofol; Remifentanil
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Completed
- Start
- 2022-03-15
- Completion
- 2023-12-14
- Enrolment
- 128
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionHemodynamic Instability; Anesthesia, General; Anesthesia, IntravenousInterventionEphedrine; Phenylephrine; Norepinephrine; Sodium chloride +2 morePhasePhase 4Registry statusCompleted